<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02605330</url>
  </required_header>
  <id_info>
    <org_study_id>193/15</org_study_id>
    <nct_id>NCT02605330</nct_id>
  </id_info>
  <brief_title>Kinetics of Plasma Fibrinogen in Cardiac Surgery</brief_title>
  <official_title>Kinetics of Plasma Fibrinogen During Cardiac and Thoracic Aortic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study intends to measure fibrinogen plasma levels during the first 24 hrs in cardiac and
      thoracic surgical patients who undergo surgical procedures using extracorporeal circulation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">September 14, 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma fibrinogen concentration</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Conventional (Clauss) and thromboelastometric measurement (FIBTEM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Periprocedural thromboembolic complications</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thoracic drain loss</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measurement of the amount of blood collected by the thoracic drain (ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit (ICU) length of stay</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet count</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measurement of platelet count in the laboratory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prothrombin time (Quick)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measurement of Quick in the laboratory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activated partial thromboplastin time (aPTT)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measurement of aPTT in the laboratory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thromboelastometric (ROTEM) parameters (e.g., INTEM, EXTEM, HEPTEM)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Measurement of ROTEM parameter (unit mm) in the laboratory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombin concentration</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Thrombin concentration in the plasma as measured in the laboratory</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Fibrinogens, Abnormal</condition>
  <arm_group>
    <arm_group_label>Fibrinogen plasma level in CABG</arm_group_label>
    <description>In all patients undergoing coronary artery bypass grafting (CABG) the investigators plan to measure the fibrinogen plasma level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fibrinogen plasma level in AVR</arm_group_label>
    <description>In all patients undergoing aortic valve replacement (AVR) the investigators plan to measure the fibrinogen plasma level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fibrinogen plasma level in AAR</arm_group_label>
    <description>In all patients undergoing aortic arch replacement (AAR) the investigators plan to measure the fibrinogen plasma level</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fibrinogen plasma level</intervention_name>
    <description>At 12 different time points investigators plan to measure the plasma fibrinogen level with conventional coagulation tests (Clauss fibrinogen) and with ROTEM.</description>
    <arm_group_label>Fibrinogen plasma level in CABG</arm_group_label>
    <arm_group_label>Fibrinogen plasma level in AVR</arm_group_label>
    <arm_group_label>Fibrinogen plasma level in AAR</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood containing all components
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiac surgery with extracorporeal bypass
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective patients undergoing coronary artery bypass grafting, aortic valve replacement
             or thoracic aortic surgery

          -  Signed written informed consent

        Exclusion Criteria:

          -  Participation in another study

          -  Language barrier to understand study purposes (e.g. french as a native language)

          -  Preoperative low level of plasma fibrinogen (&lt; 1.75 g/l)

          -  Preoperative anemia (Hb &lt; 10g/dl)

          -  Emergency treatment

          -  Intake of anticoagulants other than aspirin within 14 days preceding surgery.

          -  Known coagulation disorder.

          -  Jehovah`s witnesses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabor Erdoes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2015</study_first_submitted>
  <study_first_submitted_qc>November 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2015</study_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

